Eversept Partners, LP

Position in TVTX — Travere Therapeutics, Inc.

CIK 1697013 NEW YORK, NY

Position in TVTX

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$45,389,656

+$29,268,713 QoQ

Shares Held

798,973

+47.2% QoQ

Ownership

0.848%

of shares outstanding

% of Portfolio

2.47%

of 13F equity value

Holder Rank

#33

of 315 holders

Holding Since

Mar 2024

10 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Eversept Partners, LP holds $859,319,346 across 72 Biotechnology names. TVTX ranks #6 (5.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ABVX	Abivax S.A.	913,880	$121,783,648
2	VERA	Vera Therapeutics, Inc.	2,212,770	$94,949,960
3	CLDX	Celldex Therapeutics, Inc.	1,785,941	$66,454,864
4	SNDX	Syndax Pharmaceuticals Inc	2,798,210	$61,168,870
5	IONS	Ionis Pharmaceuticals Inc	664,684	$52,702,794
6	TVTX	Travere Therapeutics, Inc. This page	798,973	$45,389,656
7	PCVX	Vaxcyte, Inc.	629,952	$36,619,109
8	GERN	Geron Corp	18,717,422	$23,958,300

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$45,389,656	798,973	+47.2%	Shares	Sole	2026-08-14
2026-03-31	$16,120,943	542,610	-53.8%	Shares	Sole	2026-05-15
2025-12-31	$44,895,527	1,174,968	-17.1%	Shares	Sole	2026-02-17
2025-09-30	$33,871,175	1,417,204	+7.8%	Shares	Sole	2025-11-14
2025-06-30	$19,462,488	1,315,033	+61.1%	Shares	Sole	2025-08-14
2025-03-31	$14,627,271	816,254	+66.5%	Shares	Sole	2025-05-15
2024-12-31	$8,540,956	490,296	-43.6%	Shares	Sole	2025-02-14
2024-09-30	$12,170,082	869,913	-20.3%	Shares	Sole	2024-11-14
2024-06-30	$8,969,376	1,091,165	+14.2%	Shares	Sole	2024-08-14
2024-03-31	$7,367,814	955,618	—	Shares	Sole	2024-05-15
No filing history on record for this holder in this stock.